Cargando…

Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity

Chk1 is phosphorylated within its C-terminal regulatory domain by the upstream ATM/ ATR kinases during checkpoint activation, however how this modulates Chk1 function is poorly understood. Here, we show that Chk1 kinase activity is rapidly stimulated in a cell cycle phase-specific manner in response...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, M, Black, EJ, Oehler, V, Gillespie, DA, Scott, MT
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857325/
https://www.ncbi.nlm.nih.gov/pubmed/19421147
http://dx.doi.org/10.1038/onc.2009.102
_version_ 1782180317203791872
author Walker, M
Black, EJ
Oehler, V
Gillespie, DA
Scott, MT
author_facet Walker, M
Black, EJ
Oehler, V
Gillespie, DA
Scott, MT
author_sort Walker, M
collection PubMed
description Chk1 is phosphorylated within its C-terminal regulatory domain by the upstream ATM/ ATR kinases during checkpoint activation, however how this modulates Chk1 function is poorly understood. Here, we show that Chk1 kinase activity is rapidly stimulated in a cell cycle phase-specific manner in response to both DNA damage and replication arrest, and that the extent and duration of activation correlates closely with regulatory phosphorylation at serines (S) S317, S345, and S366. Despite their evident co-regulation, substitutions of individual Chk1 regulatory sites with alanine (A) residues have differential effects on checkpoint proficiency and kinase activation. Thus, whereas Chk1 S345 is essential for all functions tested, mutants lacking S317 or S366 retain partial proficiency for G2/ M and S/ M checkpoint arrests triggered by DNA damage or replication arrest. These phenotypes reflect defects in Chk1 kinase induction, since the mutants are either partially (317A, 366A) or completely (345A) resistant to kinase activation. Importantly, S345 phosphorylation is impaired in Chk1 S317A and S366A mutants, suggesting that modification of adjacent SQ sites promotes this key regulatory event. Finally, we provide biochemical evidence that Chk1 catalytic activity is stimulated via a de-repression mechanism.
format Text
id pubmed-2857325
institution National Center for Biotechnology Information
language English
publishDate 2009
record_format MEDLINE/PubMed
spelling pubmed-28573252010-04-20 Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity Walker, M Black, EJ Oehler, V Gillespie, DA Scott, MT Oncogene Article Chk1 is phosphorylated within its C-terminal regulatory domain by the upstream ATM/ ATR kinases during checkpoint activation, however how this modulates Chk1 function is poorly understood. Here, we show that Chk1 kinase activity is rapidly stimulated in a cell cycle phase-specific manner in response to both DNA damage and replication arrest, and that the extent and duration of activation correlates closely with regulatory phosphorylation at serines (S) S317, S345, and S366. Despite their evident co-regulation, substitutions of individual Chk1 regulatory sites with alanine (A) residues have differential effects on checkpoint proficiency and kinase activation. Thus, whereas Chk1 S345 is essential for all functions tested, mutants lacking S317 or S366 retain partial proficiency for G2/ M and S/ M checkpoint arrests triggered by DNA damage or replication arrest. These phenotypes reflect defects in Chk1 kinase induction, since the mutants are either partially (317A, 366A) or completely (345A) resistant to kinase activation. Importantly, S345 phosphorylation is impaired in Chk1 S317A and S366A mutants, suggesting that modification of adjacent SQ sites promotes this key regulatory event. Finally, we provide biochemical evidence that Chk1 catalytic activity is stimulated via a de-repression mechanism. 2009-05-04 2009-06-18 /pmc/articles/PMC2857325/ /pubmed/19421147 http://dx.doi.org/10.1038/onc.2009.102 Text en
spellingShingle Article
Walker, M
Black, EJ
Oehler, V
Gillespie, DA
Scott, MT
Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
title Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
title_full Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
title_fullStr Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
title_full_unstemmed Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
title_short Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation via derepression of Chk1 catalytic activity
title_sort chk1 c-terminal regulatory phosphorylation mediates checkpoint activation via derepression of chk1 catalytic activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857325/
https://www.ncbi.nlm.nih.gov/pubmed/19421147
http://dx.doi.org/10.1038/onc.2009.102
work_keys_str_mv AT walkerm chk1cterminalregulatoryphosphorylationmediatescheckpointactivationviaderepressionofchk1catalyticactivity
AT blackej chk1cterminalregulatoryphosphorylationmediatescheckpointactivationviaderepressionofchk1catalyticactivity
AT oehlerv chk1cterminalregulatoryphosphorylationmediatescheckpointactivationviaderepressionofchk1catalyticactivity
AT gillespieda chk1cterminalregulatoryphosphorylationmediatescheckpointactivationviaderepressionofchk1catalyticactivity
AT scottmt chk1cterminalregulatoryphosphorylationmediatescheckpointactivationviaderepressionofchk1catalyticactivity